InvestorsHub Logo
Followers 27
Posts 3134
Boards Moderated 0
Alias Born 01/23/2007

Re: hutschi post# 314563

Thursday, 10/19/2017 8:58:50 AM

Thursday, October 19, 2017 8:58:50 AM

Post# of 345605
and Shilyansky from 2011

http://europepmc.org/abstract/med/21628073

Phosphatidylserine inhibits NF?B and p38 MAPK activation in human monocyte derived dendritic cells.
(PMID:21628073)
Abstract

Doffek K , Chen X , Sugg SL , Shilyansky J

Molecular Immunology [31 May 2011, 48(15-16):1771-1777]

Type: Journal Article
DOI: 10.1016/j.molimm.2011.04.021 The Digital Object Identifier (DOI) System enables identification of digital entities

Abstract
Phosphatidylserine (PS) is an anionic phospholipid restricted to the inner surface of the plasma membrane. PS translocates to the cell surface during early apoptosis where it serves as a marker for rapid uptake by phagocytes. PS is also thought to regulate immune responses. Dendritic cells (DC) are the most potent antigen presenting cells. Previous studies demonstrated that PS inhibits the expression of MHC and co-stimulatory molecules, the secretion of IL-12p70, and the ability to activate T cells by human monocyte derived DCs. However, the cell signaling mechanisms by which PS regulated DCs are not well described. In the current study we tested the effects of PS on signal transduction pathways thought to regulate human myeloid DC maturation and IL-12p70 production. We showed that PS inhibited the activation of nuclear factor-?B (NF?B) in response to LPS by preventing I?Ba phosphorylation and degradation. PS also increased the total I?Ba levels in immature DCs and inhibited p38 mitogen activated protein kinase (MAPK) phosphorylation and activation. The findings suggest a possible mechanism for regulating the immunostimulatory function of DCs by PS.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News